View in EDS

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Saved in:
Bibliographic Details
Title: Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.
Authors: Parakh S; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia., Huynh N; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Cao DD; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Rigopoulos A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Gloria B; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia., Murone C; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Wichmann CW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia., Guo NY; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Senko C; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia., Parslow A; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Allan L; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Osellame LD; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia., Janes PW; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia., Scott FE; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Liu Z; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia., Gan HK; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2025 Sep 02; Vol. 24 (9), pp. 1442-1452.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40358499
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Parakh+S%22">Parakh S</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Huynh+N%22">Huynh N</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Cao+DD%22">Cao DD</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Rigopoulos+A%22">Rigopoulos A</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Gloria+B%22">Gloria B</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Burvenich+IJG%22">Burvenich IJG</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Murone+C%22">Murone C</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Wichmann+CW%22">Wichmann CW</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Guo+NY%22">Guo NY</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Senko+C%22">Senko C</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Parslow+A%22">Parslow A</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Allan+L%22">Allan L</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Osellame+LD%22">Osellame LD</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Janes+PW%22">Janes PW</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+FE%22">Scott FE</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Gan+HK%22">Gan HK</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; Department of Medical Oncology, Austin Health, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Scott+AM%22">Scott AM</searchLink>; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, Australia.; School of Cancer Medicine, Latrobe University, Melbourne, Australia.; Department of Medicine, University of Melbourne, Melbourne, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2025 Sep 02; Vol. 24 (9), pp. 1442-1452.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40358499
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-24-0583
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1442
    Titles:
      – TitleFull: Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parakh S
      – PersonEntity:
          Name:
            NameFull: Huynh N
      – PersonEntity:
          Name:
            NameFull: Cao DD
      – PersonEntity:
          Name:
            NameFull: Rigopoulos A
      – PersonEntity:
          Name:
            NameFull: Gloria B
      – PersonEntity:
          Name:
            NameFull: Burvenich IJG
      – PersonEntity:
          Name:
            NameFull: Murone C
      – PersonEntity:
          Name:
            NameFull: Wichmann CW
      – PersonEntity:
          Name:
            NameFull: Guo NY
      – PersonEntity:
          Name:
            NameFull: Senko C
      – PersonEntity:
          Name:
            NameFull: Parslow A
      – PersonEntity:
          Name:
            NameFull: Allan L
      – PersonEntity:
          Name:
            NameFull: Osellame LD
      – PersonEntity:
          Name:
            NameFull: Janes PW
      – PersonEntity:
          Name:
            NameFull: Scott FE
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Gan HK
      – PersonEntity:
          Name:
            NameFull: Scott AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Sep 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1